Search

PHILADELPHIA, (JUNE 10, 2024) – Michael Petrizzo and Julia Taylor, corporate attorneys with more than 50 years of combined experience, have joined Saul Ewing LLP as new partners. While Ms. Taylor is resident in the firm’s Washington, D.C. office, Mr. Petrizzo is resident in Philadelphia with a...

A bipartisan group of representatives, led by Representatives Maria Elvira Salazar (R-FL) and Veronica Escobar (D-TX), have introduced an updated version of the Dignity Act (H.R. 3599) to fix what they call the nation’s fractured immigration system. The authors of the bill call it the first serious...

With Kimble v. Marvel Entertainment, LLC , the U.S. Supreme Court upheld the controversial Brulotte v.Thys Co. decision, which prohibited collection of patent-based royalties that accrue after patent expiration. The Court expressly supported alternative licensing terms and business arrangements to...

Saul Ewing LLP represented Genesis Unicorn Capital, LLC, in its acquisition of and role as the sole sponsor for Genesis Unicorn Capital Corp. a special purpose acquisition company (SPAC), in the SPAC's $75 Million initial public offering (IPO) of 7,500,000 units at a price of $10.00 per unit. The...

Saul Ewing LLP represented Signal Hill Acquisition Corp., a special purpose acquisition company, in its initial public offering of 10,000,000 units at a price of $10.00 per unit, resulting in gross proceeds of $100,000,000. The units are listed on The Nasdaq Global Market (Nasdaq) and began trading...

Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...